Nanomerics Joins Royal Society of Chemistry Broadening Horizons Programme
LONDON, UK | ACCESSWIRE | September 23, 2022 | Nanomerics Ltd ., a private speciality pharmaceutical company, specialising in developing drugs based on its Molecular Envelope Technology, today announced that the company was joining the Royal Society of Chemistry''s Broadening Horizons Programme . The funded initiative is aimed at diversifying personnel within the UK chemical sciences industrial sector and follows on from the Royal Society of Chemistry''s research, which revealed that Black and minority ethnic chemists were leaving the industry, due to a lack of progression and other factors. Nanomerics'' Chief Scientific Officer, Professor Ijeoma F. Uchegbu, said, "I am delighted that Nanomerics will be offering a paid internship to underrepresented ethnic minority chemists as part of the Royal Society of Chemistry''s bold Broadening Horizon programme". The BBC News article may be accessed here . Nanomerics is focused on developing innovative medicines using its Molecular Envelope Technology (MET).
Nanomerics Joins Royal Society of Chemistry Broadening Horizons Programme
LONDON, UK | ACCESSWIRE | September 23, 2022 | Nanomerics Ltd ., a private speciality pharmaceutical company, specialising in developing drugs based on its Molecular Envelope Technology, today announced that the company was joining the Royal Society of Chemistry''s Broadening Horizons Programme . The funded initiative is aimed at diversifying personnel within the UK chemical sciences industrial sector and follows on from the Royal Society of Chemistry''s research, which revealed that Black and minority ethnic chemists were leaving the industry, due to a lack of progression and other factors. Nanomerics'' Chief Scientific Officer, Professor Ijeoma F. Uchegbu, said, "I am delighted that Nanomerics will be offering a paid internship to underrepresented ethnic minority chemists as part of the Royal Society of Chemistry''s bold Broadening Horizon programme". The BBC News article may be accessed here . Nanomerics is focused on developing innovative medicines using its Molecular Envelope Technology (MET).